| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.56B | 4.25B | 4.49B | 5.80B | 5.05B | 4.64B |
| Gross Profit | 1.31B | 1.58B | 1.91B | 2.39B | 2.19B | 2.07B |
| EBITDA | 254.30M | 737.40M | 786.20M | 1.30B | 1.19B | 1.04B |
| Net Income | -534.90M | 339.90M | 1.32B | 736.50M | 739.60M | 552.40M |
Balance Sheet | ||||||
| Total Assets | 12.08B | 11.65B | 11.93B | 11.17B | 10.67B | 10.19B |
| Cash, Cash Equivalents and Short-Term Investments | 497.70M | 357.30M | 302.40M | 572.00M | 516.80M | 568.90M |
| Total Debt | 4.54B | 3.50B | 4.11B | 3.42B | 3.34B | 3.44B |
| Total Liabilities | 8.28B | 7.14B | 7.49B | 7.77B | 7.53B | 7.20B |
| Stockholders Equity | 3.77B | 4.49B | 4.41B | 3.38B | 3.12B | 2.96B |
Cash Flow | ||||||
| Free Cash Flow | -409.40M | 603.20M | -520.30M | 440.10M | 720.00M | 580.60M |
| Operating Cash Flow | -317.50M | 671.10M | -386.40M | 582.40M | 820.10M | 647.80M |
| Investing Cash Flow | 235.10M | 263.60M | -154.40M | -266.40M | -112.00M | -169.30M |
| Financing Cash Flow | 163.50M | -870.10M | 331.50M | -237.40M | -747.90M | -250.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $12.08B | 9.42 | 27.46% | 2.56% | 12.59% | 31.40% | |
65 Neutral | $7.72B | 6.30 | 10.00% | 3.70% | 3.82% | 239.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | $6.56B | 18.12 | 6.15% | 3.36% | 1.77% | -8.72% | |
50 Neutral | $3.44B | 23.61 | ― | 4.52% | -3.93% | ― | |
47 Neutral | $1.65B | -3.09 | -11.52% | 16.68% | -13.42% | -136.59% | |
28 Underperform | $272.09M | -0.20 | -46.59% | ― | ― | 55.04% |
FMC Company is facing a significant decrease in its stock price, prompting it to test its goodwill and other intangible assets for impairment as per generally accepted accounting principles. This could lead to a substantial non-cash impairment charge, although it is not expected to affect the company’s cash flows from current or future operations.
On December 8, 2025, FMC Corporation and its subsidiaries entered into an amendment to their credit agreement, which modifies financial covenants and extends the covenant relief period to December 31, 2028. The amendment imposes limits on subsidiary indebtedness and dividend increases, and requires maintaining a minimum value of intellectual property, with provisions for asset liens if credit ratings fall below specified levels.
On December 3, 2025, Anthony DiSilvestro resigned from FMC Corporation’s Board of Directors and all its committees due to increased professional commitments and scheduling conflicts after becoming the Chief Financial Officer of Keurig Dr Pepper Inc. on November 25, 2025. FMC expressed gratitude for his service and contributions during his tenure on the Board.
On October 29, 2025, FMC Corporation announced that Ronaldo Pereira will step down as President effective December 15, 2025, after 28 years with the company. Pereira, a veteran in the crop protection industry, has significantly impacted FMC’s operations in Latin America and North America. He will remain in an advisory role until his departure to ensure a smooth transition.